VRDN
Viridian Therapeutics, Inc. · Healthcare
Chief Medical Officer Barrett Katz sold $1.1M of Viridian Therapeutics, Inc.
Sold$1,078,261
$37.18Price
29,000Shares
−100%Stake
What VRDN did after the filing
- The stock from Wed, Jan 18 close, $36.80
- −11.5%
- S&P 500, same days
- +1.6%
Measured over 30 trading days, to the Mar 2 close.
Traded Fri, Jan 13. Filed Wed, Jan 18, 12:58 PM ET, during the session. Returns use the Jan 18 close and the Mar 2 close. Not investment advice.